AREVIRUMAB-3
LIVE

Serial Number

87595746

Owner

ZALGEN LABS LLC

Attorney

Glenn H. Lenzen

First Use Date

Apr 1, 2018

Filing Date

Sep 5, 2017

Add to watchlist:

No watchlists yet
View on USPTO

AREVIRUMAB-3 Trademark

Serial Number: 87595746 • Registration: 5552263

AREVIRUMAB-3 is a trademark filed by ZALGEN LABS LLC on September 5, 2017. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ZALGEN LABS LLC (9 trademarks)

20271 GOLDENROD LN
GERMANTOWN, MD 20876

Entity Type: 16

Trademark Details

Filing Date

September 5, 2017

Registration Date

August 28, 2018

First Use Anywhere

April 1, 2018

First Use in Commerce

April 1, 2018

Published for Opposition

January 16, 2018

Goods & Services

Research and development services in the field of antibodies

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 13, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 13, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 16, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 28, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 25, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 24, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 20, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 19, 2018 AITU
USE AMENDMENT FILED
Jun 26, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 26, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 13, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2017 CNSA
ASSIGNED TO EXAMINER
Dec 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2017 NWOS
NEW APPLICATION ENTERED
Sep 8, 2017 NWAP